Artwork
iconShare
 
Manage episode 515273792 series 3638443
Content provided by Dailin Schafer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dailin Schafer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode, we unpack the surge in employer coverage for costly GLP-1 weight-loss drugs and the ripple effects on benefits design, fairness, and company budgets. We also explore how the food industry is racing to launch “GLP-1-friendly” products—and what this says about incentives, personal responsibility, and whether drugs are becoming the benefit instead of a tool.

Get the top 40+ AI Models for $20 at AI Box: ⁠⁠https://aibox.ai

  continue reading

359 episodes